ENA0000GenomicsMultiomicsSurgical Oncology Research Labs, Medicine, MGHhttps://www.ebi.ac.uk/ena/browser/view/PRJNA120193This SuperSeries is composed of the SubSeries listed below. Overall design: Refer to individual SeriesENAadvanced, malignant ovary neoplasm, ovarian neoplasm, vif Gene, tumor of the ovary, vif, cancer of the ovary, Gene, cancer of ovary, sor, A Genes, sor Gene, somatic, malignant tumour of ovary, ovarian cancer, carcinoma of ovary, survival, ovarian carcinoma, ovarian malignant tumour, epithelial, malignant tumor of the ovary, malignant Ovarian tumor, malignant ovarian tumor, malignant ovarian tumour, precocious, ovary carcinoma, ovary cancer, Q Gene, A, vif Genes, Q Genes, carcinoma of the ovary, Genes, malignant tumor of ovary, sor Genes, Q, ovarian epithelial cancer, OC, epithelial ovarian cancer, malignant neoplasm of the ovary, primary ovarian cancer, early, ovary neoplasm, malignant neoplasm of ovary, malignant ovarian neoplasm, EOS, tumor of the Ovary, ovarian malignant tumor, time of survival., tumour of the ovary, A Gene, malignant tumour of the ovary0.00.00.00.00.00falseA gene signature predictive for outcome in advanced ovarian cancer identifies a novel survival factor: MAGP22022-05-122013-05-31PRJNA120193GSE1852119962670